{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:12:10Z","timestamp":1648599130702},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1684\/bdc.2013.1823","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:02:13Z","timestamp":1565726533000},"page":"1043-1047","source":"Crossref","is-referenced-by-count":1,"title":["Actualit\u00e9s mol\u00e9culaires et th\u00e9rapeutiques dans la Leuc\u00e9mie \u00e0 Tricholeucocytes"],"prefix":"10.1016","volume":"100","author":[{"given":"Marie","family":"Balsat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2013.1823_bib0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.V13.7.609.609","article-title":"Leukemic reticuloendotheliosis","volume":"13","author":"Bouroncle","year":"1958","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V61.2.349.349","article-title":"Response to splenectomy in 65 patients with hairy cell leukemia : an evaluation of spleen weight and bone marrow involvement","volume":"61","author":"Golomb","year":"1983","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0015","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2007.15.7420","article-title":"Hairy cell leukemia : treatment successes in the past 25 years","volume":"26","author":"Golomb","year":"2008","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"10.1684\/bdc.2013.1823_bib0020","first-page":"3605","article-title":"Epidemiology of hairy cell leukemia in Los Angeles County","volume":"50","author":"Bernstein","year":"1990","journal-title":"Cancer research"},{"key":"10.1684\/bdc.2013.1823_bib0025","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2891.2891","article-title":"Improved Survival in Hairy Cell Leukemia Over Three Decades : A SEER Database Analysis of Prognostic Factors","volume":"120","author":"Chandran","year":"2012","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood.V51.5.851.851","article-title":"Infections in hairy-cell leukemia","volume":"51","author":"Bouza","year":"1978","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5507\/bp.2007.021","article-title":"Spontaneous splenic rupture in two patients with hematologic malignancy","volume":"151","author":"Szotkowski","year":"2007","journal-title":"Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia"},{"key":"10.1684\/bdc.2013.1823_bib0040","first-page":"606","article-title":"Hairy cell leukemia and autoimmune hemolytic anemia","volume":"6","author":"Domingo","year":"1992","journal-title":"Leukemia"},{"key":"10.1684\/bdc.2013.1823_bib0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnci\/djk030","article-title":"Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia : a population-based study","volume":"99","author":"Hisada","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1684\/bdc.2013.1823_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood-2009-06-195370","article-title":"How I treat hairy cell leukemia","volume":"115","author":"Grever","year":"2010","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0055","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/1097-0142(19840401)53:7<1533::AID-CNCR2820530719>3.0.CO;2-7","article-title":"Aplastic anemia terminating in hairy cell leukemia. A report of two cases","volume":"53","author":"Krause","year":"1984","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1823_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.leukres.2012.11.021","article-title":"Distinguishing hairy cell leukemia variant from hairy cell leukemia : Development and validation of diagnostic criteria","volume":"37","author":"Shao","year":"2013","journal-title":"Leukemia research"},{"key":"10.1684\/bdc.2013.1823_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1365-2559.2002.01314.x","article-title":"Splenic small B-cell lymphoma with predominant red pulp involvement : a diffuse variant of splenic marginal zone lymphoma ?","volume":"40","author":"Mollejo","year":"2002","journal-title":"Histopathology"},{"key":"10.1684\/bdc.2013.1823_bib0070","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond : evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ctrv.2010.05.003","article-title":"Hairy-cell leukemia variant : recent view on diagnosis, biology and treatment","volume":"37","author":"Robak","year":"2011","journal-title":"Cancer treatment reviews"},{"key":"10.1684\/bdc.2013.1823_bib0080","first-page":"181","article-title":"Predominance of a distinct subtype of hairy cell leukemia in Japan","volume":"7","author":"Machii","year":"1993","journal-title":"Leukemia"},{"key":"10.1684\/bdc.2013.1823_bib0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1684\/bdc.2013.1823_bib0090","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1684\/bdc.2013.1823_bib0095","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"The New England journal of medicine"},{"key":"10.1684\/bdc.2013.1823_bib0100","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"The New England journal of medicine"},{"key":"10.1684\/bdc.2013.1823_bib0105","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/leu.2008.14","article-title":"BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias","volume":"22","author":"Davidsson","year":"2008","journal-title":"Leukemia"},{"key":"10.1684\/bdc.2013.1823_bib0110","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/sj.bjc.6601371","article-title":"BRAF mutations in non-Hodgkin's lymphoma","volume":"89","author":"Lee","year":"2003","journal-title":"British journal of cancer"},{"key":"10.1684\/bdc.2013.1823_bib0115","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/sj.onc.1206398","article-title":"Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways","volume":"22","author":"Kamiguti","year":"2003","journal-title":"Oncogene"},{"key":"10.1684\/bdc.2013.1823_bib0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3324\/haematol.2012.078071","article-title":"Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia","volume":"98","author":"Tiacci","year":"2013","journal-title":"Haematologica"},{"key":"10.1684\/bdc.2013.1823_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2011-08-371179","article-title":"Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation","volume":"119","author":"Tiacci","year":"2012","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0130","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood-2011-10-383323","article-title":"Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia","volume":"119","author":"Schnittger","year":"2012","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0135","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","article-title":"Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis","volume":"145","author":"Else","year":"2009","journal-title":"British journal of haematology"},{"key":"10.1684\/bdc.2013.1823_bib0140","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V93.8.2471","article-title":"Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia","volume":"93","author":"Saven","year":"1999","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ctrv.2006.04.010","article-title":"Current treatment options in hairy cell leukemia and hairy cell leukemia variant","volume":"32","author":"Robak","year":"2006","journal-title":"Cancer treatment reviews"},{"key":"10.1684\/bdc.2013.1823_bib0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1600-0609.2008.01190.x","article-title":"Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia","volume":"82","author":"Benz","year":"2009","journal-title":"European journal of haematology"},{"key":"10.1684\/bdc.2013.1823_bib0155","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2011-04-351502","article-title":"Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia","volume":"118","author":"Ravandi","year":"2011","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0160","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/G6299513NGLCUB1K","article-title":"Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene","volume":"119","author":"Sausville","year":"2003","journal-title":"American journal of clinical pathology"},{"key":"10.1684\/bdc.2013.1823_bib0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-119-4-199308150-00005","article-title":"Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2\u2019-deoxycoformycin","volume":"119","author":"Saven","year":"1993","journal-title":"Annals of internal medicine"},{"key":"10.1684\/bdc.2013.1823_bib0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mayocp.2011.09.001","article-title":"My treatment approach to hairy cell leukemia","volume":"87","author":"Naik","year":"2012","journal-title":"Mayo Clinic proceedings. Mayo Clinic"},{"key":"10.1684\/bdc.2013.1823_bib0175","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1182\/blood-2011-08-371989","article-title":"Fludarabine and rituximab for relapsed or refractory hairy cell leukemia","volume":"119","author":"Gerrie","year":"2012","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0180","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1002\/cncr.25243","article-title":"Hairy cell leukemia : evaluation of the long-term outcome in 121 patients","volume":"116","author":"Zinzani","year":"2010","journal-title":"Cancer"},{"key":"10.1684\/bdc.2013.1823_bib0185","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/bmt.2009.293","article-title":"Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia","volume":"45","author":"Busemann","year":"2010","journal-title":"Bone marrow transplantation"},{"key":"10.1684\/bdc.2013.1823_bib0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198208193070805","article-title":"Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantation","volume":"307","author":"Cheever","year":"1982","journal-title":"The New England journal of medicine"},{"key":"10.1684\/bdc.2013.1823_bib0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"The New England journal of medicine"},{"key":"10.1684\/bdc.2013.1823_bib0200","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMc1202124","article-title":"BRAF inhibition in refractory hairy-cell leukemia","volume":"366","author":"Dietrich","year":"2012","journal-title":"The New England journal of medicine"},{"key":"10.1684\/bdc.2013.1823_bib0205","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1200\/JCO.2012.45.9495","article-title":"Continued Response off Treatment After BRAF Inhibition in Refractory Hairy Cell Leukemia","volume":"31","author":"Dietrich","year":"2013","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"10.1684\/bdc.2013.1823_bib0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.12201","article-title":"Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib","volume":"161","author":"Follows","year":"2013","journal-title":"British journal of haematology"},{"key":"10.1684\/bdc.2013.1823_bib0215","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.1802.1802","article-title":"Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Blocks Hairy Cell Leukemia (HCL) Survival, Proliferation, and BCR Signaling : A New Therapeutic Approach for HCL","volume":"120","author":"Sivina","year":"2012","journal-title":"Blood"},{"key":"10.1684\/bdc.2013.1823_bib0220","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2896.2896","article-title":"Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox","volume":"120","author":"Kreitman","year":"2012","journal-title":"Blood"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115302137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115302137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:25:39Z","timestamp":1602491139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115302137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0007455115302137"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2013.1823","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}